This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignees: Edigene Therapeutics (Beijing) Inc., Peking University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 666 
Years Active: 2023
Title: Nengyin Liu: Innovator in RNA Editing Technologies
Introduction
Nengyin Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of RNA editing, showcasing his expertise through innovative methods and compositions. His work has the potential to impact various applications in biotechnology and medicine.
Latest Patents
Nengyin Liu holds a patent titled "Methods and compositions for editing RNAs." This patent provides methods for editing RNA by introducing a deaminase-recruiting RNA in a host cell for the deamination of an adenosine in a target RNA. The application further details deaminase-recruiting RNAs used in these RNA editing methods and compositions comprising the same. He has 1 patent to his name.
Career Highlights
Throughout his career, Nengyin Liu has worked with notable organizations, including Edigene Therapeutics (Beijing) Inc. and Peking University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his coworkers include Pengfei Yuan and Yanxia Zhao. Their collective efforts have advanced the understanding and application of RNA editing technologies.
Conclusion
Nengyin Liu's innovative work in RNA editing exemplifies the potential of scientific research to transform biotechnology. His contributions continue to pave the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile